Diffusion Pharmaceuticals' CEO David Kalergis Interviewed by The Life Sciences Report
SAN FRANCISCO, CA--(Marketwired - March 31, 2016) - It takes extraordinary dexterity to execute a strategic merger, and then to take first steps toward positioning a new molecular entity for a Phase 3 drug trial and potential partnership with a big pharma. …